Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. The company is headquartered in Dusseldorf, Nordrhein-Westfalen and currently employs 13,632 full-time employees. The company went IPO on 2007-06-11. The company operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syringes. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceutical jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The firm operates approximately 40 production facilities in Europe, North America, South America and Asia.
Follow-Up Questions
What is the price performance of GRRMF stock?
The current price of GRRMF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Gerresheimer AG?
Gerresheimer AG belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Gerresheimer AG market cap?
Gerresheimer AG's current market cap is $0
Is Gerresheimer AG a buy, sell, or hold?
According to wall street analysts, 22 analysts have made analyst ratings for Gerresheimer AG, including 4 strong buy, 10 buy, 9 hold, 0 sell, and 4 strong sell
